The ENDO 2026 study, which analyzed data from 204 countries and territories, found that the global burden of heart disease is increasingly driven by rising obesity rates, causing cardiovascular disease (CVD) to occur at younger ages, according to researchers presenting Monday at the Endocrine Society’s annual meeting in Chicago.

The study reports that heart disease rates now peak among people aged 50 to 54, a shift from the traditional pattern where the highest rates were seen in much older adults.

South Asia emerged as the fastest-growing hotspot for obesity-linked heart disease, with age-standardized rates and trends increasing more than three times faster than global averages, the study showed. Investigators described obesity as a factor “rewriting” global heart disease trends by shifting CVD from a predominantly late-life condition to one increasingly affecting people in mid-life. The Endocrine Society characterized this trend as a significant emerging global health crisis, urging policy responses that explicitly target obesity to reduce premature cardiovascular disease.

A 2024 global assessment titled “The Silent Surge: Obesity Driving a Global Cardiovascular Crisis” estimated that more than 1 billion people worldwide currently live with obesity, nearly doubling the figure since 1990. When overweight individuals are included, nearly 2.5 billion adults are affected. The report estimates that high body mass index (BMI) contributes to approximately 1.9 million cardiovascular deaths annually. The World Heart Federation has stated that obesity is a key risk factor for cardiovascular disease and noted that obesity rates have been steadily increasing over the past three decades across nearly all regions.

Data from U.S. sources illustrate the shift toward earlier heart disease onset. The Centers for Disease Control and Prevention’s WONDER database shows that obesity-related ischemic heart disease deaths increased by about 180% between 1999 and 2020, with the highest mortality rates observed among middle-aged adults aged 55 to 64. These trends highlight the growing impact of obesity on cardiovascular health in working-age populations. Clinical research from a 12-year cohort study at Johns Hopkins University found that adults with a BMI of 35 or higher and elevated high-sensitivity troponin—a marker of subclinical heart muscle injury—were nine times more likely to develop heart failure, underscoring the cardiovascular risks faced by younger, metabolically healthy adults with obesity.

The mechanisms by which obesity drives premature heart disease include its direct promotion of hypertension, type 2 diabetes, dyslipidemia, sleep apnea, and systemic inflammation, according to a scientific statement from the American Heart Association (AHA). A large Mendelian randomization and epidemiologic study published in the European Heart Journal found that each 5 kg/m² increase in BMI raises the risk of heart failure by about 41% and coronary heart disease by 15%, providing strong evidence of a causal relationship. Furthermore, obesity itself, even without classic risk factors, is linked to myocardial injury, as elevated troponin levels in obese adults predict future heart failure, supporting the concept of obesity cardiomyopathy.

Global burden analyses indicate that from 1990 to 2023, high BMI contributed to more than a twofold increase in deaths and disability-adjusted life years (DALYs) from cardiovascular diseases, particularly ischemic heart disease, hypertensive heart disease, ischemic stroke, and intracranial hemorrhage. The “Silent Surge” report emphasized that high BMI is now responsible for an estimated 1.9 million cardiovascular deaths annually, making obesity a leading modifiable driver of global cardiovascular mortality. The World Heart Federation has highlighted that in many regions, more people now live with obesity than with underweight, underscoring obesity’s significance as a public health problem worldwide.

The shift of peak heart disease burden into the early 50s is further supported by global data showing that while ischemic heart disease deaths remain highest after age 70, DALYs from high-BMI-related cardiovascular disease peak between ages 50 and 69, indicating maximal loss of healthy life in mid-life. Analyses also reveal that the risk of premature cardiovascular mortality associated with overweight and obesity begins in early adulthood, with excess risk especially pronounced among those who develop obesity at younger ages.

South Asia’s rapid increase in obesity-linked heart disease is attributed to factors including urbanization, dietary shifts toward ultra-processed foods, and rising rates of obesity and diabetes, according to global cardiovascular policy statements. The World Heart Federation and allied organizations note that South Asian populations often experience cardiovascular disease at younger ages and at lower BMI thresholds than other populations, amplifying the impact of the current obesity surge on premature cardiovascular disease. Equity-focused interventions are urgently needed in lower- and lower-middle-income regions, including South Asia, where the cardiometabolic transition is occurring rapidly.

Policy responses recommended by international health organizations include adopting national obesity action plans aligned with the World Health Organization’s 2022 “Acceleration Plan to STOP Obesity,” which sets clear targets through 2030 and calls for robust accountability mechanisms. The American Heart Association classifies obesity as a major, independent, and modifiable risk factor for cardiovascular disease and advocates for integrated prevention and treatment strategies across the life course. Global frameworks such as the WHO Acceleration Plan to Stop Obesity, the Global Action Plan for the Prevention and Control of Noncommunicable Diseases, and the Global Strategy on Diet, Physical Activity and Health explicitly link obesity control to reducing cardiovascular disease burden. Recommended interventions include taxing sugary drinks, restricting marketing of unhealthy foods to children, improving front-of-pack nutrition labeling, and redesigning urban environments to promote physical activity.

The study, published in 2026, analyzed more than 11,000 adults without known pre-existing conditions, drawn from a prospective, multicenter population cohort. Researchers used whole-body MRI scans combined with a deep learning algorithm to measure lean muscle mass and intermuscular adipose tissue—fat hidden within muscles along the spine. According to Dr. Ziegelmayer, a lead investigator on the project, the analysis revealed that higher amounts of this hidden muscle fat were linked to increased odds of hypertension, unstable blood sugar, and unhealthy cholesterol levels, independent of traditional body size measures such as body mass index.

The findings showed that 16.2% of participants had undiagnosed high blood pressure, 8.5% exhibited abnormal blood sugar levels, and 45.9% presented with unhealthy lipid profiles despite being classified as healthy by conventional standards, the study reported.

These cardiometabolic abnormalities persisted after adjusting for variables including age, sex, physical activity, and study site, underscoring the potential significance of muscle composition as a distinct risk factor.

The research also highlighted the protective role of lean muscle mass, particularly in men. Higher lean muscle mass was associated with better cardiometabolic outcomes, while lower muscle mass correlated with increased risk factors. The sex-specific analysis, adjusted for gender differences, indicated that the protective effect of muscle mass was more pronounced in men, though elevated intermuscular fat was linked to higher cardiometabolic risks in both sexes. The authors cautioned that these findings do not imply women are unaffected but suggest differences in how muscle composition influences risk.

Physical activity emerged as a key modifiable factor affecting muscle composition. Participants with lower levels of physical activity tended to have more intermuscular adipose tissue and less lean muscle mass, according to the study. Researchers emphasized strength training as a relevant intervention to improve muscle health and potentially reduce cardiometabolic risk, based on the observed associations.

Dr. Ziegelmayer noted that the research team focused on a population without known disease to identify early markers of risk. He described the presence of substantial cardiometabolic risk factors in these ostensibly healthy adults as a significant finding. The study’s authors proposed that MRI-based assessment of muscle composition could serve as an imaging biomarker to augment traditional risk screening methods. They suggested that such imaging might be used opportunistically during routine MRI procedures to identify individuals at higher risk who might otherwise be missed.

The study was conducted across multiple centers and involved data collection in 2026, with the final analysis completed and published within the same year. The research received attention from outlets associated with the Radiological Society of North America (RSNA), which highlighted the potential for MRI to detect hidden risk factors in people who appear metabolically healthy by standard clinical measures.

This work represents an initial step toward integrating muscle composition metrics into cardiovascular and metabolic risk assessment. Future research may explore how incorporating intermuscular fat measurements into screening protocols could improve early detection and prevention strategies for heart disease and metabolic disorders.